1. 232 DIFFERENTIAL GENETIC EXPRESSION AND REDUCED LONGITUDINAL FUNCTION IN PATIENTS WITH DIABETES AND SEVERE AORTIC STENSOIS WITH A NORMAL EJECTION FRACTION. (24th May 2013) Authors: Ashrafi, R; Gerges, J Y; Hart, G; Boyett, M; Davis, G; Wilding, J Journal: Heart Issue: Volume 99(2013)Supplement 2 Page Start: A125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diabetes and sleep apnoea: a hidden epidemic?. Issue 11 (27th October 2006) Authors: Wilding, J Journal: Thorax Issue: Volume 61:Issue 11(2006) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. (14th October 2021) Authors: Oyama, K; Raz, I; Cahn, A; Goodrich, E; Bhatt, D; Leiter, L; McGuire, D; Wilding, J; Gause-Nilsson, I; Mosenzon, O; Sabatine, M; Wiviott, S Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0209 Observational study on the effects of il-6 inhibitor therapy on myostatin in patients with rheumatoid arthritis. (15th June 2017) Authors: Chapman, MJ; Narayanan, RP; Cross, A; Moots, R; Wilding, J; Goodson, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗